THRD
Third Harmonic Bio Inc.
NASDAQ: THRD · HEALTHCARE · BIOTECHNOLOGY
$5.38
+0.00% today
Updated 2026-04-29
Market cap
$242.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.24
Dividend yield
—
52W range
$5 – $6
Volume
—
Third Harmonic Bio Inc. (THRD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Operating cash flow | $-9.19M | $-15.75M | $-34.92M | $-20.43M | $-34.50M |
| Capital expenditures | $36000.00 | $36000.00 | $36000.00 | $169000.00 | $10000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $195000.00 | $510000.00 | $4.75M | $9.58M | $11.09M |
| Free cash flow | $-9.22M | $-15.78M | $-34.95M | $-20.59M | $-34.51M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |